Context Therapeutics Inc. · NASDAQ:CNTX
Great Point Partners LLC's stake in Context Therapeutics Inc. fell to 2.44% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Great Point Partners LLC's stake in Context Therapeutics Inc. fell to 2.44%, 2,238,496 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 2.44%
- Shares
- 2,238,496
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Great Point Partners, LLC | 2.44% | 2,238,496 |
| Dr. Jeffrey R. Jay, M.D. | 2.44% | 2,238,496 |
| Ms. Lillian Nordahl | 2.44% | 2,238,496 |
Source
Related
- Context Therapeutics Inc.
- Great Point Partners LLC
- Context Therapeutics Inc. shareholders
- Schedule 13G/A · Great Point Partners LLC · Feb 17, 2026
- Schedule 13G/A · Great Point Partners LLC · Nov 14, 2025
- Schedule 13G/A · Great Point Partners LLC · Aug 14, 2025
- Schedule 13G/A · Great Point Partners LLC · May 15, 2025
- Schedule 13G/A · Great Point Partners LLC · Feb 14, 2025
- Schedule 13G/A · Mpm Bioimpact LLC · Aug 14, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · Aug 12, 2026
- Schedule 13G/A · Octagon Capital Advisors LP · Jul 31, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G · Octagon Capital Advisors LP · May 14, 2026